Detalhe da pesquisa
1.
Phase 2 prospective open label study of neoadjuvant nab-paclitaxel, trastuzumab, and pertuzumab in patients with HER2-positive primary breast cancer.
Cancer
; 129(5): 740-749, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36517940
2.
Predicting Hyperglycemia Among Patients Receiving Alpelisib Plus Fulvestrant for Metastatic Breast Cancer.
Oncologist
; 28(7): e488-e492, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36943382
3.
Phase I Trial of Ipatasertib Plus Carboplatin, Carboplatin/Paclitaxel, or Capecitabine and Atezolizumab in Metastatic Triple-Negative Breast Cancer.
Oncologist
; 28(7): e498-e507, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37023705
4.
Immunogenicity and efficacy of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple-negative breast cancer.
Cancer Immunol Immunother
; 72(9): 3013-3027, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37294342
5.
SMARCA4/BRG1-deficient Uterine Neoplasm With Hybrid Adenosarcoma and Carcinoma Features: Expanding the Molecular-morphologic Spectrum of SMARCA4-driven Gynecologic Malignancies.
Int J Gynecol Pathol
; 2023 Dec 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38113031
6.
Physics approaches to the spatial distribution of immune cells in tumors.
Rep Prog Phys
; 84(2): 022601, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33232952
7.
Metabolic syndrome risk components and mortality after triple-negative breast cancer diagnosis in postmenopausal women in the Women's Health Initiative.
Cancer
; 127(10): 1658-1667, 2021 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33476042
8.
Phase II Trial of Neoadjuvant Carboplatin and Nab-Paclitaxel in Patients with Triple-Negative Breast Cancer.
Oncologist
; 26(3): e382-e393, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33098195
9.
A Phase II Clinical Trial of Pembrolizumab and Enobosarm in Patients with Androgen Receptor-Positive Metastatic Triple-Negative Breast Cancer.
Oncologist
; 26(2): 99-e217, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33141975
10.
Phase I clinical trial of the combination of eribulin and everolimus in patients with metastatic triple-negative breast cancer.
Breast Cancer Res
; 21(1): 119, 2019 11 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31703728
11.
Pathway activity profiling of growth factor receptor network and stemness pathways differentiates metaplastic breast cancer histological subtypes.
BMC Cancer
; 19(1): 881, 2019 Sep 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31488082
12.
CCNE1 amplification is associated with poor prognosis in patients with triple negative breast cancer.
BMC Cancer
; 19(1): 96, 2019 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30665374
13.
Medication-Related Osteonecrosis of the Jaw: Successful Medical Management of Complex Maxillary Alveolus with Sinus Involvement.
Case Rep Oncol
; 16(1): 397-413, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37384201
14.
Oral Chronic Graft-versus-Host Disease in Post-Hematopoietic Stem Cell Transplant Patients Following SARS-CoV-2 Vaccination: Case Reports.
Case Rep Oncol
; 16(1): 1287-1292, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37928865
15.
BRCA germline mutations in multiethnic gynecologic patients: A 10-year retrospective analysis from a single cancer institute.
PLoS One
; 18(6): e0286998, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37310942
16.
Hyperglycemia and Glycemic Variability Associated with Glucocorticoids in Women without Pre-Existing Diabetes Undergoing Neoadjuvant or Adjuvant Taxane Chemotherapy for Early-Stage Breast Cancer.
J Clin Med
; 12(5)2023 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36902693
17.
CF33-hNIS-anti-PD-L1 oncolytic virus followed by trastuzumab-deruxtecan in a patient with metastatic triple negative breast cancer: a case study.
Ther Adv Med Oncol
; 15: 17588359231210675, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38028143
18.
Genomic and epigenomic BRCA alterations predict adaptive resistance and response to platinum-based therapy in patients with triple-negative breast and ovarian carcinomas.
Sci Transl Med
; 14(652): eabn1926, 2022 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35857626
19.
Genomic Markers of CDK 4/6 Inhibitor Resistance in Hormone Receptor Positive Metastatic Breast Cancer.
Cancers (Basel)
; 14(13)2022 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35804935
20.
Phase II Study Combining Pembrolizumab with Aromatase Inhibitor in Patients with Metastatic Hormone Receptor Positive Breast Cancer.
Cancers (Basel)
; 14(17)2022 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36077811